Is mechanism-based pain treatment attainable? Clinical trial issues

Journal of Pain

Volumn 1, Issue 3 SUPPL., 2000, Pages 2-9

  Max, Mitchell B ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Analgesics; Chronic pain; Pain measurement

Indexed keywords

ADENOSINE RECEPTOR STIMULATING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; AMPA RECEPTOR ANTAGONIST; ANALGESIC AGENT; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; DIAMORPHINE; KETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PHENTOLAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CHRONIC PAIN; CONFERENCE PAPER; DISEASE CLASSIFICATION; HUMAN; INDIVIDUALIZATION; MEDICAL DECISION MAKING; NONHUMAN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; TREATMENT PLANNING;

EID: 0033830197     PISSN: 15265900     EISSN: None     Source Type: Journal    
DOI: 10.1054/jpai.2000.9819     Document Type: Conference Paper

References (37)

1. Towards a mechanism-based classification of pain?
2. Comments on Woolf et al
3. Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients
4. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood
5. Desipramine relieves postherpetic neuralgia
6. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms
7. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia
8. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched' enrollment trial design
9. Intravenous infusion of the NMDA antagonist, ketamine, in chronic post-traumatic pain and allodynia: A double-blind comparison with alfentanil and placebo
10. The combination of oral morphine and ketamine improves pain relief in postherpetic neuralgia compared with morphine or ketamine alone. A randomised, double-blind, placebo-controlled crossover comparison
11. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action
12. Classification of chronic pain
13. Pain: Acute pain
14. Neuropathic pain: Aetiology, symptoms, mechanisms, and management
15. Painful neuropathy: Altered central processing maintained dynamically by peripheral input
16. Sensory testing of pathophysiological mechanisms of pain in patients with reflex sympathetic dystrophy
17. Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain
18. Preclinical models of nociception
19. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: A combined analysis of controlled, single-dose studies
20. Size is everything - Large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects
21. Do different types of chronic pain require different measurement technologies?
22. Increasing the reliability and validity of pain intensity measurement in chronic pain patients
23. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury
24. Antidepressant therapy for unexplained symptoms and symptom syndromes
25. Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled trial
26. A visceral pain pathway in the dorsal column of the spinal cord
27. Peripheral contributions to visceral hyperalgesia
28. Peptides and the primary afferent nociceptor
29. Development and preliminary validation of a pain measure specific to neuropathic pain: The neuropathic pain scale
30. The short-form McGill Pain Questionnaire
31. The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man
32. Crossover and self-controlled designs in clinical research